(Q39362773)

11 September 2017

Letter: Growth-hormone response to bromocriptine in parkinsonism (English)

1 reference

11 September 2017

1 reference

2

A J Lees

1 reference

11 September 2017

K M Shaw

1

1 reference

11 September 2017

S Hayes

3

1 reference

11 September 2017

E J Ross

4

1 reference

11 September 2017

G M Stern

5

1 reference

11 September 2017

B D Thompson

6

1 reference

11 September 2017

language of work or name

English

0 references

publication date

1 January 1976

1 reference

11 September 2017

1 reference

11 September 2017

1

1 reference

11 September 2017

7952

1 reference

11 September 2017

194

1 reference

Neural regulation of growth hormone secretion

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

Stimulation of Human-Growth-Hormone Secretion by L-Dopa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

1 reference

7 January 2021

Defective Release of Growth Hormone in Parkinsonism Improved by Levodopa

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

Endocrine Function and Glucose Metabolism in Patients with Parkinson's Disease and their Alteration byl-Dopa1

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

Effect of L-dopa administration on growth hormone secretion in normal subjects and Parkinsonian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

Inhibitory effect of L-Dopa on GH release in acromegalic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

Bromocriptine treatment of acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

Changes in Plasma Growth Hormone Levels in Normal and Acromegalic Subjects Following Administration of 2-Bromo-α-Ergocryptine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

Letter: Bromocriptine in parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2876%2991298-8

7 January 2021

10.1016/S0140-6736(76)91298-8

Identifiers

DOI

1 reference

11 September 2017

1 reference